MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    403.98 Kb
  • HTML
    190.15 Kb
Add to My Favorites
You must be logged in to use this functionality
Loading full text...

Full text loading...

1. Abdulla, S.,, R. Oberholzer,, O. Juma,, S. Kubhoja,, F. Machera,, C. Membi,, S. Omari,, A. Urassa,, H. Mshinda,, A. Jumanne,, N. Salim,, M. Shomari,, T. Aebi,, D. M. Schellenberg,, T. Carter,, T. Villafana,, M. A. Demoitié,, M. C. Dubois,, A. Leach,, M. Lievens,, J. Vekemans,, J. Ghen,, W. R. Ballou,, and M. Tanner. 2008. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N. Engl. J. Med. 359:25332544.
1a. Achtman, A. H.,, P. C. Bull,, R. Stephens,, and J. Langhorne. 2005. Longevity of the immune response and memory to blood-stage malaria infection. Curr. Top. Microbiol. Immunol. 297:71102.
2. Acosta, C. J.,, C. M. Galindo,, D. Schellenberg,, J. J. Aponte,, E. Kahigwa,, H. Urassa,, J. R. Schellenberg,, H. Masanja,, R. Hayes,, A. Y. Kitua,, F. Lwilla,, H. Mshinda,, C. Menendez,, M. Tanner,, and P. L. Alonso. 1999. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania. Trop. Med. Int. Health 4:368376.
3. Aide, P.,, Q. Bassat,, and P. L. Alonso. 2007. Towards an effective malaria vaccine. Arch. Dis. Child. 92:476479.
4. Aikawa, M.,, J. R. Rabbege,, I. Udeinya,, and L. H. Miller. 1983. Electron microscopy of knobs in Plasmodium falciparum-infected erythrocytes. J. Parasitol. 69:435437.
5. Alkin, S. S. 2004. Monoclonal antibodies: the story of a discovery that revolutionized science and medicine. Nat. Rev. Immunol. 4:153156.
6. Alonso, P. L.,, T. Smith,, J. R. Schellenberg,, H. Masanja,, S. Mwankusye,, H. Urassa,, I. Bastos de Azevedo,, J. Chongela,, S. Kobero,, C. Menendez, et al. 1994. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344:11751181.
7. Altman, L. K. 1987. Who Goes First? The Story of Self-Experimentation in Medicine. Random House, New York, NY.
8. Anonymous. 1989. AID's Malaria Vaccine Research Activities. General Accounting Office, Washington, DC.
9. Anonymous. 1975. Malaria vaccine on the horizon. Br. Med. J. 1:231232. (Editorial.)
10. Anonymous. 2007. Is malaria eradication possible? Lancet 370:1459.
11. Anonymous. 1998, posting date. Miodrag Ristic Investigation File, 1963–67, 1980–92.
12. Anonymous. 1963. Obituary. Jules Freund 1890–1960. J. Immunol. 90:331336.
13. Anonymous. 1993. Retired prof convicted of fraud. Researcher to perform 300 hours of service, pay $50,000. http://www.illinimedia.com/di/archives/1993/February/22/prof.html. Illini Media Co. Champaign, IL.
14. Anonymous. 1993. Scientist accused of theft retains post. Science 260:1415.
15. Aponte, J. J.,, P. Aide,, M. Renom,, I. Mandomando,, Q. Bassat,, J. Sacarlal,, M. N. Manaca,, S. Lafuente,, A. Barbosa,, A. Leach,, M. Lievens,, J. Vekemans,, B. Sigauque,, M. C. Dubois,, M. A. Demoitie,, M. Sillman,, B. Savarese,, J. G. McNeil,, E. Macete,, W. R. Ballou,, J. Cohen,, and P. L. Alonso. 2007. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 370:15431551.
16. Arakawa, T.,, A. Komesu,, H. Otsuki,, J. Sattabongkot,, R. Udomsangpetch,, Y. Matsumoto,, N. Tsuji,, Y. Wu,, M. Torii,, and T. Tsuboi. 2005. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infect. Immun. 73:73757380.
17. Ardeshir, F.,, J. E. Flint,, and R. T. Reese. 1985. Expression of Plasmodium falciparum surface antigens in Escherichia coli. Proc. Natl. Acad. Sci. USA 82:25182522.
18. Ardeshir, F.,, J. E. Flint,, S. J. Richman,, and R. T. Reese. 1987. A 75 kd merozoite surface protein of Plasmodium falciparum which is related to the 70 kd heat-shock proteins. EMBO J. 6:493499.
19. Arese, P.,, K. Ayi,, A. Skorokhod,, and F. Turrini,. 2006. Removal of early parasite forms from circulation as a mechanism of resistance against malaria in widespread red blood cell mutations, p. 2553. In K. R. Dronamraju, and P. Arese (ed.), Malaria: Genetic and Evolutionary Aspects. Springer, New York, NY.
20. Aucouturier, J.,, S. Ascarateil,, and L. Dupuis. 2006. The use of oil adjuvants in therapeutic vaccines. Vaccine 24S2:S2/44S42/45.
21. Avril, M.,, B. Gamain,, C. Lepolard,, N. Viaud,, A. Scherf,, and J. Gysin. 2006. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. Microbes Infect. Inst. Pasteur 8:28632871.
22. Babon, J. J.,, W. D. Morgan,, G. Kelly,, J. F. Eccleston,, J. Feeney,, and A. A. Holder. 2007. Structural studies on Plasmodium vivax merozoite surface protein-1. Mol. Biochem. Parasitol. 153:3140.
23. Ballou, W. R. 2007. Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine. Microbes Infect. Inst. Pasteur 9:761766.
24. Ballou, W. R.,, and C. P. Cahill. 2007. Two decades of commitment to malaria vaccine development: GlaxoSmithKline Biologicals. Am. J. Trop. Med. Hyg. 77:289295.
25. Ballou, W. R.,, S. L. Hoffman,, J. A. Sherwood,, M. R. Hollingdale,, F. A. Neva,, W. T. Hockmeyer,, D. M. Gordon,, I. Schneider,, R. A. Wirtz,, J. F. Young, et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 329:12771281.
26. Bannister, L.,, A. Margos,, and J. Hopkins,. 2005. Making a home for Plasmodium post-genomics: ultrastructural organization of the blood stages, p. 2449. In I. W. Sherman (ed.), Molecular Approaches to Malaria. ASM Press, Washington, DC.
27. Bannister, L.,, and G. H. Mitchell. 2003. The ins, outs and roundabouts of malaria. Trends Parasitol. 19:209213.
28. Bannister, L. H.,, G. A. Butcher,, E. D. Dennis,, and G. H. Mitchell. 1975. Structure and invasive behaviour of Plasmodium knowlesi merozoites in vitro. Parasitology 71:483491.
29. Barcia, J. J. 2007. The Giemsa stain: its history and applications. Int. J. Surg. Pathol. 15:292296.
30. Bardes, C. L. 2008. Pale Faces. The Masks of Anemia. Bellevue, New York, NY.
31. Barnwell, J. W.,, R. J. Howard,, H. G. Coon,, and L. H. Miller. 1983. Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria. Infect. Immun. 40:985994.
32. Barnwell, J. W.,, R. J. Howard,, and L. H. Miller. 1982. Altered expression of Plasmodium knowlesi variant antigen on the erythrocyte membrane in splenectomized rhesus monkeys. J. Immunol. 128:224226.
33. Barnwell, J. W.,, M. E. Nichols,, and P. Rubinstein. 1989. In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax. J. Exp. Med. 169:17951802.
34. Baruch, D. I. 1999. Adhesive receptors on malaria-parasitized red cells. Baillieres Best Pract. Res. Clin. Haematol. 12:747761.
35. Baruch, D. I.,, B. Gamain,, and L. H. Miller. 2003. DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses. Infect. Immun. 71:45364543.
36. Baruch, D. I.,, B. L. Pasloske,, H. B. Singh,, X. Bi,, X. C. Ma,, M. Feldman,, T. F. Taraschi,, and R. J. Howard. 1995. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82:7787.
37. Baumler, E. 1984. Paul Ehrlich, Scientist for Life. Holmes and Meier, New York, NY.
38. Beaudoin, R. L. 1977. Should cultivated exoerythrocytic parasites be considered as a source of antigen for a malaria vaccine? Bull. W. H. O. 55:373376.
39. Beaudoin, R. L.,, C. P. Strome,, F. Mitchell,, and T. A. Tubergen. 1977. Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp. Parasitol. 42:15.
40. Beaudoin, R. L.,, C. P. Strome,, T. A. Tubergen,, and F. Mitchell. 1976. Plasmodium berghei berghei: irradiated sporozoites of the ANKA strain as immunizing antigens in mice. Exp. Parasitol. 39:438443.
40a. Bejon, P.,, J. Lusingu,, A. Olotu,, A. Leach,, M. Lievens,, J. Vekemans,, S. Mshamu,, T. Lang,, J. Gould,, M. C. Dubois,, M. A. Demoitié,, J. F. Stallaert,, P. Vansadia,, T. Carter,, P. Njunguna,, K. O. Awuondo,, A. Malabeja,, O. Abdul,, S. Gesase,, N. Mturi,, C. J. Drakeley,, B. Savarese,, T. Villafana,, W. R. Ballou,, J. Cohen,, G. M. Riley,, M. M. Lemnge,, K. Marsh,, and L. von Seidlein. 2008. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N. Engl. J. Med. 359:25212532.
41. Belnoue, E.,, F. T. Costa,, T. Frankenberg,, A. M. Vigario,, T. Voza,, N. Leroy,, M. M. Rodrigues,, I. Landau,, G. Snounou,, and L. Renia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172:24872495.
42. Biagini, G. A.,, P. M. O'Neill,, P. G. Bray,, and S. A. Ward. 2005. Current drug development portfolio for antimalarial therapies. Curr. Opin. Pharmacol. 5:16.
43. Biello, D. 5 March 2008, posting date. Lending a helping arm: volunteers risk malaria to test vaccine. Sci. Am. Online
44. Bignami, A.,, and G. Bastianelli. 1890. Observazioni suile febbri malariche estive-autunnali. Rif. Medi. 232:13341335.
45. Biswas, P. 1999. Patterns of parasitemia, antibodies, complement and circulating immune complexes in drug-suppressed simian Plasmodium knowlesi malaria. Indian J. Malariol. 36:3341.
46. Bitragunta, S.,, M. V. Murhekar,, Y. J. Hutin,, P. P. Penumur,, and M. D. Gupte. 2008. Persistence of diphtheria, Hyderabad, India, 2003–2006. Emerg. Infect. Dis. 14:11441146.
47. Blackman, M. J.,, T. J. Scott-Finnigan,, S. Shai,, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389393.
48. Boffey, P. M. 1984. Malaria vaccine is near, U.S. health officials say. New York Times. New York, NY.
49. Boffey, P. M. 1988. U.S. Malaria Program, roiled by harassment dispute, faces new security. New York Times. New York, NY.
50. Bojang, K. A.,, S. K. Obaro,, U. D'Alessandro,, S. Bennett,, P. Langerock,, G. A. Targett,, and B. M. Greenwood. 1998. An efficacy trial of the malaria vaccine SPf66 in Gambian infants—second year of followup. Vaccine 16:6267.
51. Boutlis, C. S.,, E. M. Riley,, N. M. Anstey,, and J. B. de Souza. 2005. Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination. Curr. Top. Microbiol. Immunol. 297:145185.
52. Brattig, N. W.,, K. Kowalsky,, X. Liu,, G. D. Burchard,, F. Kamena,, and P. H. Seeberger. 2008. Plasmodium falciparum glycosylphosphatidylinositol toxin interacts with the membrane of non-parasitized red blood cells: a putative mechanism contributing to malaria anemia. Microbes Infect. Inst. Pasteur 10:885891.
53. Bray, R. S. 1976. Vaccination against Plasmodium falciparum: a negative result. Trans. R. Soc. Trop. Med. Hyg. 70:258.
54. Brock, T. 1999. Robert Koch, a Life in Medicine. ASM Press, Washington, DC.
55. Brooke, J. 1993. Colombian physician challenges malaria on the home front. New York Times, New York, NY.
56. Brown, E. M. 2000. Why Wagner-Jauregg won the Nobel prize for discovering malaria therapy for general paresis of the insane. Hist. Psychiatry 11:371382.
57. Brown, H. 2007. Obituary. Sir Ian Alexaner McGregor. Lancet 369:134.
58. Brown, K. N. 1973. Antibody-induced variation in malaria parasites. Nature 242:4950.
59. Brown, K. N., 1976. Resistance to malaria, p. 268295. In S. Cohen, and E. Sadun (ed.), Immunology of Parasitic Infections. Blackwell, Oxford, United Kingdom.
60. Brown, K. N.,, and I. N. Brown. 1965. Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature 208: 12861288.
61. Brown, K. N.,, I. N. Brown,, and L. A. Hills. 1970. Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp. Parasitol. 28:304317.
62. Brown, K. N.,, and J. Williamson. 1962. Antigens of brucei trypanosomes. Nature 194:12531255.
63. Brown, P. 1991. Trials and tribulations of a malaria vaccine: one of the most hopeful candidates for a malaria vaccine emerged from an area where the disease is endemic. Its results have raised expectations and scientific controversy. New Sci. 129:1820.
64. Bueding, E. 1962. Comparative biochemistry of parasitic helminths. Comp. Biochem. Physiol. 4:343351.
65. Butcher, G. A.,, and S. Cohen. 1972. Antigenic variation and protective immunity in Plasmodium knowlesi malaria. Immunology 23:503521.
66. Butcher, G. A.,, S. Cohen,, and P. C. Garnham. 1970. Passive immunity in Plasmodium knowlesi malaria. Trans. R. Soc. Trop. Med. Hyg. 64:850856.
67. Butcher, G. A.,, G. H. Mitchell,, and S. Cohen. 1973. Mechanism of host specificity in malarial infection. Nature 244:4041. (Letter.)
68. Bynum, J.,, and C. Overy. 1998. The Beast in the Mosquito: the Correspondence of Ronald Ross and Patrick Manson. Rodopi, Amsterdam, The Netherlands.
69. Camus, D.,, and T. J. Hadley. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230:553556.
70. Carter, R. 2002. Spatial simulation of malaria transmission and its control by malaria transmission blocking vaccination. Int. J. Parasitol. 32:16171624.
71. Carter, R. 2001. Transmission blocking malaria vaccines. Vaccine 19:23092314.
72. Carter, R.,, and D. H. Chen. 1976. Malaria transmission blocked by immunisation with gametes of the malaria parasite. Nature 263:5760.
73. Carter, R.,, R. W. Gwadz,, and I. Green. 1979. Plasmodium gallinaceum: transmission-blocking immunity in chickens. II. The effect of antigamete antibodies in vitro and in vivo and their elaboration during infection. Exp. Parasitol. 47:194208.
74. Carter, R.,, R. W. Gwadz,, and F. M. McAuliffe. 1979. Plasmodium gallinaceum: transmission-blocking immunity in chickens. I. Comparative immunogenicity of gametocyte- and gamete-containing preparations. Exp. Parasitol. 47:185193.
75. Carter, R.,, and D. C. Kaushal. 1984. Characterization of antigens on mosquito midgut stages of Plasmodium gallinaceum. III. Changes in zygote surface proteins during transformation to mature ookinete. Mol. Biochem. Parasitol. 13:235241.
76. Cassier, M. 2005. Appropriatrion and commercialization of the Pasteur anthrax vaccine. Stud. Hist. Philos. Biol. Biomed. Sci. 36:722742.
77. Cates, L.,, S. James,, G. Jennings,, W. Hockmeyer,, and R. Ballou. 2003. External evaluation of the USAID Malaria Vaccine Development Project. U.S. Agency for International Development, Washington, DC.
78. Cavasini, C. E.,, L. C. Mattos,, A. A. Couto,, C. R. Bonini-Domingos,, S. H. Valencia,, W. C. Neiras,, R. T. Alves,, A. R. Rossit,, L. Castilho,, and R. L. Machado. 2007. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans. R. Soc. Trop. Med. Hyg. 101:10421044.
79. Chakravarty, S.,, I. A. Cockburn,, S. Kuk,, M. G. Overstreet,, J. B. Sacci,, and F. Zavala. 2007. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 13:10351041.
80. Chang, K. H.,, and M. M. Stevenson. 2004. Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during bloodstage malaria. Int. J. Parasitol. 34:15011516.
81. Chatterjee, S.,, J. L. Perignon,, E. Van Marck,, and P. Druilhe. 2006. How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations. J. Postgrad. Med. 52:321324.
82. Chen, Q.,, A. Heddini,, A. Barragan,, V. Fernandez,, S. F. Pearce,, and M. Wahlgren. 2000. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J. Exp. Med. 192:110.
83. Chen, Q.,, F. Pettersson,, A. M. Vogt,, B. Schmidt,, S. Ahuja,, P. Liljestrom,, and M. Wahlgren. 2004. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine 22:27012712.
84. Chernin, E. 1984. The malariatherapy of neurosyphilis. J. Parasitol. 70:611617.
85. Chitnis, C. E. 2001. Molecular insights into receptors used by malaria parasites for erythrocyte invasion. Curr. Opin. Hematol. 8:8591.
86. Clark, I. A.,, A. C. Allison,, and F. E. Cox, 1976. Protection of mice against Babesia and Plasmodium. Nature 259:309311.
87. Clark, I. A.,, E. J. Wills,, J. E. Richmond,, and A. C. Allison. 1977. Suppression of babesiosis in BCG–infected mice and its correlation with tumor inhibition. Infect. Immun. 17:430438.
88. Clyde, D. F. 1990. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies 1971–75. Bull. W. H. O. 68(Suppl. 1):912.
89. Clyde, D. F. 1975. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24: 397401.
90. Clyde, D. F.,, H. Most,, and J. Vanderberg. 1973. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:169177.
91. Coatney, G. R.,, W. E. Collins,, M. Warren,, and P. G. Contacos. 1971. The Primate Malarias. U.S. Government Printing Office, Bethesda, MD.
92. Cochrane, A. H.,, R. Nussenzweig,, and E. Nardin,. 1980. Immunization against sporozoites, p. 163202. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, San Diego, CA.
93. Cockburn, I. A.,, M. J. Mackinnon,, A. O'Donnell,, S. J. Allen,, J. M. Moulds,, M. Baisor,, M. Bockarie,, J. C. Reeder,, and J. A. Rowe. 2004. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad. Sci. USA 101:272277.
94. Coggeshall, L. T. 1938. Plasmodium lophurae, a new species of malaria pathogenic for the domestic fowl. Am. J. Hyg. 27:615618.
95. Coggeshall, L. T.,, and M. Eaton. 1938. Complement fixation reaction in monkey malaria. J. Exp. Med. 66:177190.
96. Coggeshall, L. T.,, and H. Kumm. 1937. Demonstration of passive immunity in experimental monkey malaria. J. Exp. Med. 66:177190.
97. Coggeshall, L. T.,, and H. Kumm. 1938. Effect of repeated superinfection upon the patency of immune serum of monkeys harboring chronic infections of Plasmodium knowlesi. J. Exp. Med. 68:1727.
98. Cohen, S. 1963. Gamma-globulin metabolism. Br. Med. J. 19:202206.
99. Cohen, S.,, and G. A. Butcher. 1970. Properties of protective malarial antibody. Nature 225:732734.
100. Cohen, S.,, G. A. Butcher,, and R. B. Crandall. 1969. Action of malarial antibody in vitro. Nature 223:368371.
101. Cohen, S.,, I. McGregor,, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733737.
102. Collins, W. E. 2002. Nonhuman primate models. I. Nonhuman primate host-parasite combinations. Methods Mol. Med. 72:7784.
103. Collins, W. E. 2002. Nonhuman primate models. II. Infection of Saimiri and Aotus monkeys with Plasmodium vivax. Methods Mol. Med. 72:8592.
103a. Collins, W. E.,, and J. W. Barnwell. 2008. A helpful beginning for malaria vaccines. N. Engl. J. Med. 359:25992601.
104. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am. J. Trop. Med. Hyg. 61:2035.
105. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am. J. Trop. Med. Hyg. 61:3643.
106. Collins, W. E.,, and G. M. Jeffery. 1999. A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61:4448.
107. Collins, W. E.,, and G. M. Jeffery. 2007. Plasmodium malariae: parasite and disease. Clin. Microbiol. Rev. 20:579592.
108. Collins, W. E.,, G. M. Jeffery,, and J. M. Roberts. 2004. A retrospective examination of reinfection of humans with Plasmodium vivax. Am. J. Trop. Med. Hyg. 70:642644.
109. Collins, W. E.,, and G. M. Jeffrey. 2005. Plasmodium ovale: parasite and disease. Clin. Microbiol. Rev. 18:570581.
110. Collins, W. E.,, J. C. Skinner,, M. Pappaioanou,, J. R. Broderson,, N. S. Ma,, V. Filipski,, P. S. Stanfill,, and L. Rogers. 1988. Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. J. Parasitol. 74:392398.
111. Cowman, A. F.,, and B. S. Crabb. 2006. Invasion of red blood cells by malaria parasites. Cell 124:755766.
112. Crandall, I.,, W. E. Collins,, J. Gysin,, and I. W. Sherman. 1993. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 90:47034707.
113. Crandall, I.,, and I. W. Sherman. 1994. Antibodies to synthetic peptides based on band 3 motifs react specifically with Plasmodium falciparum (human malaria)-infected erythrocytes and block cytoadherence. Parasitology 108:389396.
114. Dahlback, M.,, T. S. Rask,, P. H. Andersen,, M. A. Nielsen,, N. T. Ndam,, M. Resende,, L. Turner,, P. Deloron,, L. Hviid,, O. Lund,, A. G. Pedersen,, T. G. Theander,, and A. Salanti. 2006. Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestration. PLoS Pathog. 2:e124.
115. Dame, J. B.,, J. L. Williams,, T. F. McCutchan,, J. L. Weber,, R. A. Wirtz,, W. T. Hockmeyer,, W. L. Maloy,, J. D. Haynes,, I. Schneider,, D. Roberts, et al. 1984. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science 225:593599.
116. Daubersies, P.,, B. Ollomo,, J. P. Sauzet,, K. Brahimi,, B. L. Perlaza,, W. Eling,, H. Moukana,, P. Rouquet,, C. de Taisne,, and P. Druilhe. 2008. Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses. PLoS ONE 3:e2659.
117. Daubersies, P.,, A. W. Thomas,, P. Millet,, K. Brahimi,, J. A. Langermans,, B. Ollomo,, L. BenMohamed,, B. Slierendregt,, W. Eling,, A. Van Belkum,, G. Dubreuil,, J. F. Meis,, C. Guerin-Marchand,, S. Cayphas,, J. Cohen,, H. Gras-Masse,, and P. Druilhe. 2000. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat. Med. 6:12581263.
118. Deane, L.,, J. Neto,, and I. Silveira. 1966. Experimental infection of a splenectomized squirrel monkey Saimiri sciureus. Trans. R. Soc. Trop. Med. Hyg. 60:811812.
119. Deans, A. M.,, S. Nery,, D. J. Conway,, O. Kai,, K. Marsh,, and J. A. Rowe. 2007. Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates. Infect. Immun. 75:30143020.
120. Deans, J. 1984. Protective antigens of blood stage Plasmodium knowlesi parasites. Philos. Trans. R. Soc. Lond. Ser. B 307:159169.
121. Deans, J. A.,, T. Alderson,, A. W. Thomas,, G. H. Mitchell,, E. S. Lennox,, and S. Cohen. 1982. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 49:297309.
122. Deans, J. A.,, A. M. Knight,, W. C. Jean,, A. P. Waters,, S. Cohen,, and G. H. Mitchell. 1988. Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kD merozoite antigen. Parasite Immunol. 10:535552.
123. Debre, P. 1998. Louis Pasteur. Johns Hopkins Press, Baltimore, MD.
124. de Kruif, P. 1926. Microbe Hunters. Harcourt Brace, San Diego, CA.
125. Dennis, E. D.,, G. H. Mitchell,, G. A. Butcher,, and S. Cohen. 1975. In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves. Parasitology 71:475481.
126. Desowitz, R. 2002. Federal Bodysnatchers and the New Guinea Virus. Norton, New York, NY.
127. Desowitz, R. 1991. The Malaria Capers. More Tales of Parasites and People, Research and Reality. Norton, New York, NY.
128. Diggs, C. L., 1980. Prospects for development of vaccines against Plasmodium falciparum infection, p. 299315. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, Inc., San Diego, CA.
129. Diggs, C. L.,, F. Hines,, and B. T. Wellde. 1995. Plasmodium falciparum: passive immunization of Aotus lemurinus griseimembra with immune serum. Exp. Parasitol. 80:291296.
130. Dobell, C. 1960. Antony van Leeuwenhoek and His “Little Animals”; Being Some Account of the Father of Protozoology and Bacteriology and His Multifarious Discoveries in These Disciplines. Dover, New York, NY.
131. Dobson, M. J. 1997. Contours of Death and Disease in Early Modern England. Cambridge University Press, Cambridge, United Kingdom.
132. Doolan, D.,, J. Dobano,, and J. K. Baird. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22:1336.
133. Doolan, D.,, and S. L. Hoffman. 2002. Nucleic acid vaccines against malaria. Chem. Immunol. 80:308321.
134. Doolan, D.,, and A. Stewart. 2007. Status of malaria R & D in 2007. Expert Rev. Vaccines 6:903905.
135. Doolan, D. L.,, R. C. Hedstrom,, W. O. Rogers,, Y. Charoenvit,, M. Rogers,, P. de la Vega,, and S. L. Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem. 271:1786117868.
136. Doolan, D. L.,, and S. L. Hoffman. 1997. Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections. Philos. Trans. R. Soc. Lond. Ser. B 352:13611367.
137. Doolan, D. L.,, and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:14531462.
138. Doolan, D. L.,, and N. Martinez-Alier. 2006. Immune response to pre-erythrocytic stages of malaria parasites. Curr. Mol. Med. 6:169185.
139. Doolan, D. L.,, Y. Mu,, B. Unal,, S. Sundaresh,, S. Hirst,, C. Valdez,, A. Randall,, D. Molina,, X. Liang,, D. A. Freilich,, J. A. Oloo,, P. L. Blair,, J. C. Aguiar,, P. Baldi,, D. H. Davies,, and P. L. Felgner. 2008. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8:46804694.
140. Doolan, D. L.,, M. Sedegah,, R. C. Hedstrom,, P. Hobart,, Y. Charoenvit,, and S. L. Hoffman. 1996. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183:17391746.
141. Doolan, D. L.,, S. Southwood,, D. A. Freilich,, J. Sidney,, N. L. Graber,, L. Shatney,, L. Bebris,, L. Florens,, C. Dobano,, A. A. Witney,, E. Appella,, S. L. Hoffman,, J. R. Yates III,, D. J. Carucci,, and A. Sette. 2003. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100:99529957.
142. Douradinha, B.,, M. R. van Dijk,, R. Ataide,, G. J. van Gemert,, J. Thompson,, J. F. Franetich,, D. Mazier,, A. J. Luty,, R. Sauerwein,, C. J. Janse,, A. P. Waters,, and M. M. Mota. 2007. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int. J. Parasitol. 37:15111519.
143. Draper, S. J.,, A. C. Moore,, A. L. Goodman,, C. A. Long,, A. A. Holder,, S. C. Gilbert,, F. Hill,, and A. V. Hill. 2008. Effective induction of high-titer antibodies by viral vector vaccines. Nat. Med. 14:819821.
144. Druilhe, P.,, and J. W. Barnwell. 2007. Pre-erythrocytic stage malaria vaccines: time for a change in path. Curr. Opin. Microbiol. 10:371378.
145. Druilhe, P.,, and C. Marchand,. 1989. From sporozoite to liver stages: the saga of the irradiated sporozoite vaccine, p. 3950. In K. P. W. McAdams (ed.), Frontiers of Infectious Diseases. New Strategies in Parasitology. Churchill Livingstone, London, United Kingdom.
146. Druilhe, P.,, L. Renia,, and D. Fidock,. 1998. Immunity to liver stages, p. 513544. In I. W. Sherman (ed.), Malaria. Parasite Biology, Pathogenesis, and Protection. ASM Press, Washington, DC.
147. Dubos, R. 1976. Louis Pasteur, Free Lance of Science. Scribners Sons, New York, NY.
148. Duffy, M. F.,, A. Caragounis,, R. Noviyanti,, H. M. Kyriacou,, E. K. Choong,, K. Boysen,, J. Healer,, J. A. Rowe,, M. E. Molyneux,, G. V. Brown,, and S. J. Rogerson. 2006. Transcribed var genes associated with placental malaria in Malawian women. Infect. Immun. 74:48754883.
149. Duffy, M. F.,, A. G. Maier,, T. J. Byrne,, A. J. Marty,, S. R. Elliott,, M. T. O'Neill,, P. D. Payne,, S. J. Rogerson,, A. F. Cowman,, B. S. Crabb,, and G. V. Brown. 2006. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 148:117124.
150. Duffy, P. E. 2007. Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia. Parasitology 134:18771881.
151. Duffy, P. E.,, and M. Fried. 2005. Malaria in the pregnant woman. Curr. Top. Microbiol. Immunol. 295:169200.
152. Duraisingh, M. T.,, A. G. Maier,, T. Triglia,, and A. F. Cowman. 2003. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 100:47964801.
153. Eaton, M. D. 1938. The agglutination of Plasmodium knowlesi by immune serum. J. Exp. Med. 67:857.
154. Eaton, M. D. 1939. The soluble malarial antigen in the serum of monkeys infected with Plasmodium knowlesi. J. Exp. Med. 69:517532.
155. Eaton, M. D.,, and L. T. Coggeshall. 1939. Production in monkeys of complement fixing antibodies without active immunity by injection of killed Plasmodium knowlesi. J. Exp. Med. 70:141146.
156. Eda, S.,, J. Lawler,, and I. W. Sherman. 1999. Plasmodium falciparuminfected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein. Mol. Biochem. Parasitol. 100:195205.
157. Eda, S.,, and I. W. Sherman. 2004. Plasmodium falciparum-infected erythrocytes bind to the RGD motif of fibronectin via the band 3-related adhesin. Exp. Parasitol. 107:157162.
158. Eisen, H. N. 2001. Michael Heidelberger 1888–1991. Biogra. Mem. Natl. Acad. Sci. 80:122140.
159. Ellis, J.,, L. S. Ozaki,, R. W. Gwadz,, A. H. Cochrane,, V. Nussenzweig,, R. S. Nussenzweig,, and G. N. Godson. 1983. Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature 302:536538.
160. Enea, V.,, D. Arnot,, E. C. Schmidt,, A. Cochrane,, R. Gwadz,, and R. S. Nussenzweig. 1984. Circumsporozoite gene of Plasmodium cynomolgi (Gombak): cDNA cloning and expression of the repetitive circumsporozoite epitope. Proc. Natl. Acad. Sci. USA 81:75207524.
161. Epstein, J. E. 2007. What will a partly protective malaria vaccine mean to mothers in Africa? Lancet 370:15231524.
162. Epstein, J. E.,, B. Giersing,, G. Mullen,, V. Moorthy,, and T. L. Richie. 2007. Malaria vaccines: are we getting closer? Curr. Opin. Mol. Ther. 9:1224.
163. Epstein, J. E.,, S. Rao,, F. Williams,, D. Freilich,, T. Luke,, M. Sedegah,, P. de la Vega,, J. Sacci,, T. L. Richie,, and S. L. Hoffman. 2007. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J. Infect. Dis. 196:145154.
164. Espinal, C.,, E. Moreno,, J. Umana,, J. Ramirez,, and M. Montilla. 1984. Susceptibility of different populations of Colombian Aotus monkeys to the FCB-1 strain of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 33:777782.
165. Eugui, E. M.,, and A. C. Allison. 1979. Malaria infections in different strains of mice and their correlation with natural killer activity. Bull. W. H. O. 57 (Suppl. 1):231238.
166. Eyles, D. 1952. Studies on Plasmodium gallinaceum. I. Factors associated with the malaria infection in the vertebrate host which influence the degree of infection in the mosquito. Am. J. Hyg. 55:386391.
167. Eyles, D. 1952. Studies on Plasmodium gallinaceum. II. Factors in the blood of the vertebrate host influencing mosquito infection. Am. J. Hyg. 55:276290.
168. Fairhurst, R. M.,, H. Fujioka,, K. Hayton,, K. F. Collins,, and T. E. Wellems. 2003. Aberrant development of Plasmodium falciparumI n hemoglobin CC red cells: implications for the malaria protective effect of the homozygous state. Blood 101:33093315.
169. Fleischer, B. 2004. 100 years ago: Giemsa's solution of staining plasmodia. Trop. Med. Inter. Health 9:755756.
170. Fortin, A.,, M. M. Stevenson,, and P. Gros. 2002. Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum. Mol. Genet. 11:24692478.
171. Franke-Fayard, B.,, C. J. Janse,, M. Cunha-Rodrigues,, J. Ramesar,, P. Buscher,, I. Que,, C. Lowik,, P. J. Voshol,, M. A. den Boer,, S. G. van Duinen,, M. Febbraio,, M. M. Mota,, and A. P. Waters. 2005. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA 102:1146811473.
172. Freeman, R. R.,, A. J. Trejdosiewicz,, and G. A. Cross. 1980. Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature 284:366368.
173. Freund, J.,, K. J. Thomson,, H. E. Sommer,, A. W. Walter,, and E. L. Schenkein. 1945. Immunization of Rhesus monkeys against malarial infection (P. knowlesi) with killed parasites and adjuvants. Science 102:202204.
174. Freund, J.,, K. Thomson,, H. Sommer,, A. Walter,, and T. Pisani. 1948. Immunization of monkeys against malaria by means of killed parasites with adjuvants. Am. J. Trop. Med. 28:122.
175. Freund, J. S.,, H. Sommer,, and A. Walter. 1945. Immunization against malaria: vaccination of ducks with killed parasites incorporated with adjuvants. Science 102:200202.
176. Frevert, U.,, and E. Nardin. 2008. Cellular effector mechanisms against Plasmodium liver stages. Cell. Microbiol. 10:19561967.
177. Fried, M.,, K. K. Hixson,, L. Anderson,, Y. Ogata,, T. K. Mutabingwa,, and P. E. Duffy. 2007. The distinct proteome of placental malaria parasites. Mol. Biochem. Parasitol. 155:5765.
178. Fried, M.,, F. Nosten,, A. Brockman,, B. J. Brabin,, and P. E. Duffy. 1998. Maternal antibodies block malaria. Nature 395:851852.
179. Galinski, M. R.,, A. R. Dluzewski,, and J. W. Barnwell,. 2005. A mechanistic approach to merozoite invasion of red blood cells: merozoite biogenesis, rupture, and invasion of erythrocytes, p. 113168. In I. W. Sherman (ed.), Molecular Approaches to Malaria. ASM Press, Washington, DC.
180. Gamage-Mendis, A. C.,, J. Rajakaruna,, R. Carter,, and K. N. Mendis. 1992. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunol. 14:385396.
181. Gardner, M. J.,, N. Hall,, E. Fung,, O. White,, M. Berriman,, R. W. Hyman,, J. M. Carlton,, A. Pain,, K. E. Nelson,, S. Bowman,, I. T. Paulsen,, K. James,, J. A. Eisen,, K. Rutherford,, S. L. Salzberg,, A. Craig,, S. Kyes,, M. S. Chan,, V. Nene,, S. J. Shallom,, B. Suh,, J. Peterson,, S. Angiuoli,, M. Pertea,, J. Allen,, J. Selengut,, D. Haft,, M. W. Mather,, A. B. Vaidya,, D. M. Martin,, A. H. Fairlamb,, M. J. Fraunholz,, D. S. Roos,, S. A. Ralph,, G. I. McFadden,, L. M. Cummings,, G. M. Subramanian,, C. Mungall,, J. C. Venter,, D. J. Carucci,, S. L. Hoffman,, C. Newbold,, R. W. Davis,, C. M. Fraser,, and B. Barrell. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498511.
182. Garnham, P. C. C. 1947. Exo-erythrocytic schizogony in Plasmodium kochi: a preliminary note. Trans. R. Soc. Trop. Med. Hyg. 40:719722.
183. Gaur, D.,, J. R. Storry,, M. E. Reid,, J. W. Barnwell,, and L. H. Miller. 2003. Plasmodium falciparumis able to invade erythrocytes through a trypsin-resistant pathway independent of glycophorin B. Infect. Immun. 71:67426746.
184. Geiman, Q. M.,, and M. J. Meagher. 1967. Susceptibility of a New World monkey to Plasmodium falciparumf rom man. Nature 215:437439.
185. Geison, G. 1990. Pasteur, Roux and rabies: scientific versus clinical mentalities. J. Hist. Med. Allied Sci. 45:341365.
186. Geison, G. 1978. Pasteur's work on rabies: re-examining the ethical issues. Hastings Center Rep. 8:2633.
187. Geison, G. 1995. The Private Science of Louis Pasteur. Princeton University Press, Princeton, NJ.
188. Good, M. F. 2005. Vaccine-induced immunity to malaria parasites and the need for novel strategies. Trends Parasitol. 21:2934.
189. Good, M. F.,, and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11:412419.
190. Good, M. F.,, and D. L. Doolan. 2007. Malaria's journey through the lymph node. Nat. Med. 13:10231024.
191. Gordon, D. M.,, T. W. McGovern,, U. Krzych,, J. C. Cohen,, I. Schneider,, R. LaChance,, D. G. Heppner,, G. Yuan,, M. Hollingdale,, M. Slaoui, et al. 1995. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite proteinhepatitis B surface antigen subunit vaccine. J. Infect. Dis. 171:15761585.
192. Grabowsky, M. 2008. The billion dollar malaria moment. Nature 451:10511052.
193. Gratepanche, S.,, B. Gamain,, J. D. Smith,, B. A. Robinson,, A. Saul,, and L. H. Miller. 2003. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc. Natl. Acad. Sci. USA 100:1300713012.
194. Graves, P.,, H. Gelband,, and P. Garner. 1998. The SPf66 malaria vaccine: what is the evidence for efficacy? Parasitol. Today 14:218220.
195. Graves, P. M. 1998. Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria. Ann. Trop. Med. Parasitol. 92:399410.
196. Graves, P. M.,, R. Carter,, T. R. Burkot,, I. A. Quakyi,, and N. Kumar. 1988. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol. 10:209218.
197. Greenwood, B. M.,, K. Bojang,, C. Whitty,, and G. Targett. 2005. Malaria. Lancet 365:14871498.
198. Grotendorst, C. A.,, N. Kumar,, R. Carter,, and D. C. Kaushal. 1984. A surface protein expressed during the transformation of zygotes of Plasmodium gallinaceum is a target of transmission-blocking antibodies. Infect. Immun. 45:775777.
199. Gruenberg, J.,, D. R. Allred,, and I. W. Sherman. 1983. Scanning electron microscope-analysis of the protrusions (knobs) present on the surface of Plasmodium falciparum-infected erythrocytes. J. Cell Biol. 97:795802.
200. Grun, J.,, and W. Weidanz. 1983. Antibody-independent immunity to reinfection malaria in B cell deficient mice. Infect. Immun. 41:11971204.
201. Gruner, A. C.,, M. Mauduit,, R. Tewari,, J. F. Romero,, N. Depinay,, M. Kayibanda,, E. Lallemand,, J. M. Chavatte,, A. Crisanti,, P. Sinnis,, D. Mazier,, G. Corradin,, G. Snounou,, and L. Renia. 2007. Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS ONE 2:e1371.
202. Guerin-Marchand, C.,, P. Druilhe,, B. Galey,, A. Londono,, J. Patarapotikul,, R. L. Beaudoin,, C. Dubeaux,, A. Tartar,, O. Mercereau-Puijalon,, and G. Langsley. 1987. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 329:164167.
203. Guillemin, J. 2002. Choosing scientific patrimony: Sir Ronald Ross, Alphonse Laveran and the mosquito hypothesis for malaria. J. Hist. Med. 57:385409.
204. Gwadz, R. W. 1976. Successful immunization against the sexual stages of Plasmodium gallinaceum. Science 193:11501151.
205. Gwadz, R. W.,, and L. C. Koontz. 1984. Plasmodium knowlesi: persistence of transmission blocking immunity in monkeys immunized with gamete antigens. Infect. Immun. 44:137140.
206. Gysin, J., 1998. Animal models: primates, p. 419441. In I. W. Sherman (ed.), Malaria. Parasite Biology, Pathognesis and Protection. ASM Press, Washington, DC.
207. Gysin, J.,, M. Hommel,, and L. P. da Silva. 1980. Experimental infection of the squirrel monkey (Saimiri sciureus) with Plasmodium falciparum. J. Parasitol. 66:10031009.
208. Hadley, T. J.,, and L. H. Miller. 1988. Invasion of erythrocytes by malaria parasites: erythrocyte ligands and parasite receptors. Prog. Allergy 41:4971.
209. Hafalla, J. C.,, A. Morrot,, G. Sano,, G. Milon,, J. J. Lafaille,, and F. Zavala. 2003. Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria. J. Immunol. 171:964970.
210. Hafalla, J. C.,, G. Sano,, L. H. Carvalho,, A. Morrot,, and F. Zavala. 2002. Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc. Natl. Acad. Sci. USA 99:1181911824.
211. Harris, P. K.,, S. Yeoh,, A. R. Dluzewski,, R. A. O'Donnell,, C. Withers-Martinez,, F. Hackett,, L. H. Bannister,, G. H. Mitchell,, and M. J. Blackman. 2005. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 1:241251.
212. Harrison, G. 1978. Mosquitoes, Malaria and Man: a History of Hostilities since 1880. Dutton, New York, NY.
213. Haynes, J. D.,, C. L. Diggs,, F. A. Hines,, and R. E. Desjardins. 1976. Culture of human malaria parasites Plasmodium falciparum. Nature 263:767769.
214. Heidelberger, M.,, W. A. Coates,, and M. Mayer. 1946. Studies in human malaria. II. Attempts to influence relapsing vivax malaria by treatment of patients with vaccine (P. vivax). J. Immunol. 52:101107.
215. Heidelberger, M.,, M. Mayer,, and C. Demarest. 1946. Studies in human malaria. I. The preparation of vaccines and suspensions containing plasmodia. J. Immunol. 52:325330.
216. Heidelberger, M.,, C. Prout,, J. Hindle,, and A. Rose. 1946. Studies in human malaria. III. An attempt at vaccination of paretics against blood-borne infection with Plasmodium vivax. J. Immunol. 52:109118.
216a. Heidelberger, M.,, M. Mayer,, A. Alving,, B. Craige,, R. Jones,, T. Pullman,, and M. Whorton. 1946. Studies in human malaria. IV. An attempt at vaccination of volunteers against mosquito-borne infection with Pl. vivax. J. Immunol. 52:113118.
217. Heppner, D. G.,, D. M. Gordon,, M. Gross,, B. Wellde,, W. Leitner,, U. Krzych,, I. Schneider,, R. A. Wirtz,, R. L. Richards,, A. Trofa,, T. Hall,, J. C. Sadoff,, P. Boerger,, C. R. Alving,, D. R. Sylvester,, T. G. Porter,, and W. R. Ballou. 1996. Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes. J. Infect. Dis. 174:361366.
218. Heppner, D. G., Jr.,, K. E. Kester,, C. F. Ockenhouse,, N. Tornieporth,, O. Ofori,, J. A. Lyon,, V. A. Stewart,, P. Dubois,, D. E. Lanar,, U. Krzych,, P. Moris,, E. Angov,, J. F. Cummings,, A. Leach,, B. T. Hall,, S. Dutta,, R. Schwenk,, C. Hillier,, A. Barbosa,, L. A. Ware,, L. Nair,, C. A. Darko,, M. R. Withers,, B. Ogutu,, M. E. Polhemus,, M. Fukuda,, S. Pichyangkul,, M. Gettyacamin,, C. Diggs,, L. Soisson,, J. Milman,, M. C. Dubois,, N. Garcon,, K. Tucker,, J. Wittes,, C. V. Plowe,, M. A. Thera,, O. K. Duombo,, M. G. Pau,, J. Goudsmit,, W. R. Ballou,, and J. Cohen. 2005. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23:22432250.
219. Herrera, S.,, B. L. Perlaza,, A. Bonelo,, and M. Arevalo-Herrera. 2002. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int. J. Parasitol. 32:16251635.
220. Herrington, D.,, J. Davis,, E. Nardin,, M. Beier,, J. Cortese,, H. Eddy,, G. Losonsky,, M. Hollingdale,, M. Sztein,, M. Levine, et al. 1991. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg. 45:539547.
221. Herrington, D. A.,, E. H. Nardin,, G. Losonsky,, I. C. Bathurst,, P. J. Barr,, M. R. Hollingdale,, R. Edelman,, and M. M. Levine. 1991. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. Am. J. Trop. Med. Hyg. 45:695701.
222. Hillier, C. J.,, L. A. Ware,, A. Barbosa,, E. Angov,, J. A. Lyon,, D. G. Heppner,, and D. E. Lanar. 2005. Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum. Infect. Immun. 73:21092115.
223. Hoffman, S. L.,, E. D. Franke,, M. R. Hollingdale,, and P. Druilhe,. 1996. Attacking the infected hepatocyte, p. 3575. In S. Hoffman (ed.), Malaria Vaccine Development: a Multi-Immune Response Approach. ASM Press, Washington, DC.
224. Hoffman, S. L.,, L. M. Goh,, T. C. Luke,, I. Schneider,, T. P. Le,, D. L. Doolan,, J. Sacci,, P. de la Vega,, M. Dowler,, C. Paul,, D. M. Gordon,, J. A. Stoute,, L. W. Church,, M. Sedegah,, D. G. Heppner,, W. R. Ballou,, and T. L. Richie. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185:11551164.
225. Hoffman, S. L.,, M. Sedegah,, and R. C. Hedstrom. 1994. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 12:15291533.
226. Hogh, B.,, E. Petersen,, I. Crandall,, A. Gottschau,, and I. W. Sherman. 1994. Immune responses to band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high hematocrit value. Infect. Immun. 62:43624366.
227. Holbrook, T., 1980. Immunizatioin against exo-erythrocytic stages of malaria parasites, p. 203230. In J. Kreier (ed.), Malaria, vol. 3. Academic Press, San Diego, CA.
228. Holder, A. A.,, and R. R. Freeman. 1982. Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J. Exp. Med. 156:15281538.
229. Holder, A. A.,, and R. R. Freeman. 1981. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 294:361364.
230. Holder, A. A.,, R. R. Freeman,, and S. C. Nicholls. 1988. Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 10:607617.
231. Holder, A. A.,, J. A. Guevara Patino,, C. Uthaipibull,, S. E. Syed,, I. T. Ling,, T. Scott-Finnigan,, and M. J. Blackman. 1999. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parasitologia 41:409414.
232. Hollingdale, M. R.,, and U. Krzych. 2002. Immune responses to liver-stage parasites: implications for vaccine development. Chem. Immunol. 80:97124.
233. Hollingdale, M. R.,, J. L. Leef,, M. McCullough,, and R. L. Beaudoin. 1981. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei from sporozoites. Science 213:10211022.
234. Hollingdale, M. R.,, P. Leland,, and A. L. Schwartz. 1983. In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in a hepatoma cell line. Am. J. Trop. Med. Hyg. 32:682684.
235. Holmes, O. W. 1909–1914. The Contagiousness of Puerperal Fever. P. F. Collier, New York, NY.
236. Hopkin, M. 2008. Malaria: the big push. Nature 451:10471049.
237. Howard, R. F.,, and R. T. Reese. 1990. Plasmodium falciparum: heterooligomeric complexes of rhoptry polypeptides. Exp. Parasitol. 71:330342.
238. Howard, R. F.,, H. A. Stanley,, and R. T. Reese. 1988. Characterization of a high-molecular-weight phosphoprotein synthesized by the human malarial parasite Plasmodium falciparum. Gene 64:6575.
239. Howard, R. F.,, A. Varki,, and R. T. Reese. 1984. Merozoite proteins synthesized in P. falciparum schizonts. Prog. Clin. Biol. Res. 155:4561.
240. Howard, R. J. 1984. Antigenic variation of bloodstage malaria parasites. Philos. Trans. R. Soc. Lond. Ser. B 307:141158.
241. Howard, R. J.,, J. W. Barnwell,, and V. Kao. 1983. Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc. Natl. Acad. Sci. USA 80:41294133.
242. Howard, R. J.,, J. W. Barnwell,, V. Kao,, W. A. Daniel,, and S. B. Aley. 1982. Radioiodination of new protein antigens on the surface of Plasmodium knowlesi schizont-infected erythrocytes. Mol. Biochem. Parasitol. 6:343367.
243. Hsu, S.,, H. F. Hsu,, and L. F. Bur